ALBBasic Materials · Specialty ChemicalsThe 23 Wall Street analysts covering Albemarle Corp. hold a median 12-month price target of $170 — +83.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 84 of 100 as at 22 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Albemarle Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (97): Reported profit is backed by cash, and the company is not expanding recklessly.
Volatility (23): The share price moves around a lot.
Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ALB, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +83.7% from it.
Of the 20 most recent actions, 0 moved their price target up and 8 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 15 Oct 2026 | RBC Capital | Maintains | Outperform | $157 → $129 |
| 14 Oct 2026 | Mizuho | Upgrade | Outperform | $130 |
| 13 Oct 2026 | Barclays | Initiates | Equal-Weight | $109 |
| 7 Oct 2026 | Argus Research | Maintains | Buy | $230 → $135 |
| 7 Oct 2026 | Argus Research | Maintains | Buy | — |
| 5 Oct 2026 | UBS | Maintains | Buy | $175 → $150 |
| 5 Oct 2026 | UBS | Maintains | Buy | — |
| 1 Oct 2026 | Mizuho | Maintains | Neutral | $140 → $130 |
| 1 Oct 2026 | Mizuho | Maintains | Neutral | — |
| 25 Aug 2026 | JP Morgan | Maintains | Neutral | — |
| 25 Aug 2026 | JP Morgan | Maintains | Neutral | $160 → $140 |
| 10 Aug 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 10 Aug 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 10 Aug 2026 | RBC Capital | Maintains | Outperform | — |
| 10 Aug 2026 | RBC Capital | Maintains | Outperform | $166 → $157 |
| 10 Aug 2026 | Scotiabank | Maintains | Sector Outperform | — |
| 10 Aug 2026 | Scotiabank | Maintains | Sector Outperform | $200 → $190 |
| 7 Aug 2026 | B of A Securities | Reiterates | Buy | — |
| 7 Aug 2026 | BMO Capital | Maintains | Outperform | — |
| 7 Aug 2026 | Citigroup | Maintains | Buy | $225 → $175 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
ALB appears in the Radar on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 22 Oct 2026, Albemarle Corp. returned +2.6% against +15.6% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 2% of US stocks
Cheaper than 53% of US stocks
Cheaper than 57% of US stocks
Cheaper than 39% of US stocks
Higher than 78% of US stocks
Higher than 98% of US stocks
Higher than 40% of US stocks
Higher than 86% of US stocks
Higher than 57% of US stocks
Higher than 49% of US stocks
Higher than 66% of US stocks
Higher than 77% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Albemarle Corp. has a market value of $11.3B and an enterprise value of $14.2B.
Revenue in the twelve months to 30 June 2026: $5.9B. The latest quarter grew 31.1% year on year.
Net income over the same four quarters: $278.5M, a 4.7% net margin.
Diluted earnings per share, trailing twelve months: $0.27.
Free cash flow in the twelve months to 30 June 2026: $1.3B, after $458.0M of capital spending.
Albemarle Corp. spent $357.4M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 347.0×; forward P/E: 8.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 1.75%, paying out 600% of earnings.
Albemarle Corp. employs 7,800 people — $757K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Albemarle Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Albemarle closed the most recent trading day at $92.54, down 2.04% from the previous session. The headline says the decline was larger than the general market’s.
Why it matters — ALB watchers may note the stock’s session decline relative to the broader market.
Albemarle closed the most recent trading session at $95.39, down 2.84% from the previous trading day. The headline characterizes the decline as more significant than the broader market’s.
Why it matters — ALB watchers may note the reported daily decline and its comparison with the broader market.
Albemarle shares rose 1.6% to $99.19 after Mizuho upgraded the stock, according to Schaeffers Research.
Why it matters — The upgrade and share move are relevant developments for investors tracking ALB.
Mizuho analyst John Roberts upgraded Albemarle stock to Buy from Hold on Tuesday evening.
Why it matters — The analyst rating change is relevant to ALB watchers tracking views of the company’s stock.
Benzinga reports that an analyst turned bullish on Albemarle, as part of a roundup of analyst outlook changes and upgrades for Wednesday. The excerpt provides no further details about the analyst or rating change.
Why it matters — The reported change in analyst outlook is relevant to ALB watchers tracking Wall Street views of the company.
The 23 Wall Street analysts covering Albemarle Corp. have a median 12-month price target of $170, with estimates ranging from $83 to $211. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 23 analysts covering Albemarle Corp., 14 rate it a Buy, 9 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Albemarle Corp. 84 out of 100 across roughly 4,600 US stocks as at 22 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Oct 2026, Albemarle Corp. ranks 84 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (97 of 100).
No one can know that. What the data says: the median 12-month target from 23 analysts implies +83.7% from the last close, and Ticker Nerd's factor model ranks Albemarle Corp. 84 out of 100 as at 22 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Albemarle Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALB are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $83 to $211 over the next 12 months.
Albemarle Corp. returned +2.6% over the 12 months to 22 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Albemarle Corporation is a global specialty chemicals company focused on lithium, bromine, and catalyst solutions. Albemarle supplies critical materials used in energy storage, electric mobility, electronics, construction, agriculture, pharmaceuticals, and petroleum refining.
The most recent item we track (Zacks Investment Research, 22 Oct 2026): "Albemarle (ALB) Suffers a Larger Drop Than the General Market: Key Insights". Albemarle closed the most recent trading day at $92.54, down 2.04% from the previous session. The headline says the decline was larger than the general market’s.
Albemarle Corporation is a global specialty chemicals company focused on lithium, bromine, and catalyst solutions. Albemarle supplies critical materials used in energy storage, electric mobility, electronics, construction, agriculture, pharmaceuticals, and petroleum refining. Its lithium products support battery supply chains for grid storage and transportation, while its bromine specialties serve flame retardants and other industrial applications. The company’s catalysts business provides technologies used in refining and chemical processing, helping customers improve product performance and operational efficiency. Albemarle operates across multiple regions and serves a broad international customer base through its Energy Storage, Specialties, and Ketjen segments. Headquartered in Charlotte, North Carolina, Albemarle plays a significant role in the specialty materials market by transforming essential resources into ingredients used in modern industrial and consumer applications.
CEO Mr. Jerry Kent Masters Jr. · 7,800 employees · United States · https://www.albemarle.com
